Cancer and inflammation: promise for biologic therapy
- PMID: 20386472
- PMCID: PMC2941912
- DOI: 10.1097/CJI.0b013e3181d32e74
Cancer and inflammation: promise for biologic therapy
Abstract
Cancers often arise as the end stage of inflammation in adults, but not in children. As such there is a complex interplay between host immune cells during neoplastic development, with both an ability to promote cancer and limit or eliminate it, most often complicit with the host. In humans, defining inflammation and the presence of inflammatory cells within or surrounding the tumor is a critical aspect of modern pathology. Groups defining staging for neoplasms are strongly encouraged to assess and incorporate measures of the presence of apoptosis, autophagy, and necrosis and also the nature and quality of the immune infiltrate. Both environmental and genetic factors enhance the risk of cigarette smoking, Helicobacter pylori, hepatitis B/C, human papilloma virus, solar irradiation, asbestos, pancreatitis, or other causes of chronic inflammation. Identifying suitable genetic polymorphisms in cytokines, cytokine receptors, and Toll-like receptors among other immune response genes is also seen as high value as genomic sequencing becomes less expensive. Animal models that incorporate and assess not only the genetic anlagen but also the inflammatory cells and the presence of microbial pathogens and damage-associated molecular pattern molecules are necessary. Identifying micro-RNAs involved in regulating the response to damage or injury are seen as highly promising. Although no therapeutic strategies to prevent or treat cancers based on insights into inflammatory pathways are currently approved for the common epithelial malignancies, there remains substantial interest in agents targeting COX2 or PPARgamma, ethyl pyruvate and steroids, and several novel agents on the horizon.
Similar articles
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
-
Mechanisms of disease: Inflammation and the origins of cancer.Nat Clin Pract Oncol. 2005 Feb;2(2):90-7; quiz 1 p following 113. doi: 10.1038/ncponc0081. Nat Clin Pract Oncol. 2005. PMID: 16264881 Review.
-
Mechanisms and pathways of innate immune activation and regulation in health and cancer.Hum Vaccin Immunother. 2014;10(11):3270-85. doi: 10.4161/21645515.2014.979640. Hum Vaccin Immunother. 2014. PMID: 25625930 Free PMC article. Review.
-
Review article: the role of inflammation in the pathogenesis of gastric cancer.Aliment Pharmacol Ther. 1999 Mar;13 Suppl 1:13-8. doi: 10.1046/j.1365-2036.1999.00003.x. Aliment Pharmacol Ther. 1999. PMID: 10209682 Review.
-
Decoding cell death signals in liver inflammation.J Hepatol. 2013 Sep;59(3):583-94. doi: 10.1016/j.jhep.2013.03.033. Epub 2013 Apr 6. J Hepatol. 2013. PMID: 23567086 Review.
Cited by
-
TREM-1low is a novel characteristic for tumor-associated macrophages in lung cancer.Oncotarget. 2016 Jun 28;7(26):40508-40517. doi: 10.18632/oncotarget.9639. Oncotarget. 2016. PMID: 27244892 Free PMC article.
-
Cancer and innate immune system interactions: translational potentials for cancer immunotherapy.J Immunother. 2012 May;35(4):299-308. doi: 10.1097/CJI.0b013e3182518e83. J Immunother. 2012. PMID: 22495387 Free PMC article. Review.
-
Long non-coding RNA expression profiles and related regulatory networks in areca nut chewing-induced tongue squamous cell carcinoma.Oncol Lett. 2020 Dec;20(6):302. doi: 10.3892/ol.2020.12165. Epub 2020 Sep 29. Oncol Lett. 2020. PMID: 33093911 Free PMC article.
-
Exploring the potential use of Chinese herbs in regulating the inflammatory microenvironment of tumours based on the concept of 'state-target identification and treatment': a scooping review.Chin Med. 2023 Sep 23;18(1):124. doi: 10.1186/s13020-023-00834-5. Chin Med. 2023. PMID: 37742025 Free PMC article. Review.
-
Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin.Mol Cancer. 2010 Dec 15;9:314. doi: 10.1186/1476-4598-9-314. Mol Cancer. 2010. PMID: 21159167 Free PMC article.
References
-
- Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M, Park M. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med. 2008;14:518–27. - PubMed
-
- Yang H, Bocchetta M, Kroczynska B, Elmishad AG, Chen Y, Liu Z, Bubici C, Mossman BT, Pass HI, Testa JR, Franzoso G, Carbone M. TNF-alpha inhibits asbestos- induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci USA. 2006;103:10397–10402. - PMC - PubMed
-
- Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–44. - PubMed
-
- Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell. 2004;6:447–58. - PubMed
-
- Zeh HJ, Lotze MT. Addicted to death: invasive cancer and the immune response to unscheduled cell death. J Immunother. 2005;28:1–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials